A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This purpose of the study is to investigate the bronchodilating effects of 3 different
dosages of formoterol given in combination with budesonide as Symbicort pMDI.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate